<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boreland AJ</submitter><funding>NCATS</funding><funding>NCATS NIH HHS</funding><funding>Rutgers Brain Health Institute</funding><funding>NIAAA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Rutgers University</funding><funding>NIGMS NIH HHS</funding><funding>Robert Wood Johnson Foundation</funding><funding>NIGMS</funding><funding>NINDS</funding><pagination>109628</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11019286</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(5)</volume><pubmed_abstract>Human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorder (HAND) affects up to half of people living with HIV-1 and causes long term neurological consequences. The pathophysiology of HIV-1-induced glial and neuronal functional deficits in humans remains enigmatic. To bridge this gap, we established a model simulating HIV-1 infection in the central nervous system using human induced pluripotent stem cell (iPSC)-derived microglia combined with sliced neocortical organoids. Incubation of microglia with two replication-competent macrophage-tropic HIV-1 strains (JRFL and YU2) elicited productive infection and inflammatory activation. RNA sequencing revealed significant and sustained activation of type I interferon signaling pathways. Incorporating microglia into sliced neoc</pubmed_abstract><journal>iScience</journal><pubmed_title>Sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoids.</pubmed_title><pmcid>PMC11019286</pmcid><funding_grant_id>R01 AA023797</funding_grant_id><funding_grant_id>T32 GM135141</funding_grant_id><funding_grant_id>R21 NS120806</funding_grant_id><funding_grant_id>TL1 TR003019</funding_grant_id><funding_grant_id>T32 GM008339</funding_grant_id><pubmed_authors>Lin HC</pubmed_authors><pubmed_authors>Hart RP</pubmed_authors><pubmed_authors>Stillitano AC</pubmed_authors><pubmed_authors>Abbo Y</pubmed_authors><pubmed_authors>Pang ZP</pubmed_authors><pubmed_authors>Rabson AB</pubmed_authors><pubmed_authors>Boreland AJ</pubmed_authors><pubmed_authors>Jiang P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoids.</name><description>Human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorder (HAND) affects up to half of people living with HIV-1 and causes long term neurological consequences. The pathophysiology of HIV-1-induced glial and neuronal functional deficits in humans remains enigmatic. To bridge this gap, we established a model simulating HIV-1 infection in the central nervous system using human induced pluripotent stem cell (iPSC)-derived microglia combined with sliced neocortical organoids. Incubation of microglia with two replication-competent macrophage-tropic HIV-1 strains (JRFL and YU2) elicited productive infection and inflammatory activation. RNA sequencing revealed significant and sustained activation of type I interferon signaling pathways. Incorporating microglia into sliced neoc</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-01T11:53:19.412Z</modification><creation>2025-04-22T13:47:25.866Z</creation></dates><accession>S-EPMC11019286</accession><cross_references><pubmed>38628961</pubmed><doi>10.1016/j.isci.2024.109628</doi></cross_references></HashMap>